CKPT(CKPT)

$4.26—

Chart

CKPT(CKPT)

NASDAQ

$4.26—

Chart Studio

CKPT(CKPT)

CKPT

Overview Stream Notebook Intel Chart History Fundamentals TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

FY2026 EPS Estimate

$1.13

FY2026E EPS$1.13

FY2027E EPS$6.17

Analyst Sentiment

Wall St. Consensus

Buy

7 analysts·Limited coverage

Score

5 Buy (71%)2 Hold (29%)0 Sell (0%)

Rating Breakdown

Strong Buy

00%

Buy

571%

Hold

229%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$4.10

-3.8%

Consensus

$4.10

-3.8%

Bull

$4.10

-3.8%

12-Month Target Range7 analysts

$4.10$4.10$4.10

Current $4.26Consensus

Current Price

$4.26

Above Consensus

$0.16

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+392.65%

EPS+446.02%

FY2028

Rev-58.06%

EPS-63.21%

FY2029

Rev+25.49%

EPS+22.47%

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E
Revenue Avg	$186M	$915M	$384M	$482M
Low	$186M	$915M	$384M	$482M
High	$186M	$915M	$384M	$482M
EBITDA Avg	$-186M	$-915M	$-384M	$-482M
Low	$-186M	$-915M	$-384M	$-482M
High	$-186M	$-915M	$-384M	$-482M
EBIT Avg	$-186M	$-915M	$-384M	$-482M
Low	$-186M	$-915M	$-384M	$-482M
High	$-186M	$-915M	$-384M	$-482M
Net Income Avg	$45M	$245M	$90M	$110M
Low	$45M	$245M	$90M	$110M
High	$45M	$245M	$90M	$110M
EPS Avg	$1.13	$6.17	$2.27	$2.78
Low	$1.13	$6.17	$2.27	$2.78
High	$1.13	$6.17	$2.27	$2.78
Analysts (Rev / EPS)	1 / 1	1 / 1	1 / 1	1 / 1

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028
Revenue Avg	$46M	$48M	$220M	$229M	$229M	$238M	$92M	$96M
Low	$46M	$48M	$220M	$229M	$229M	$238M	$92M	$96M
High	$46M	$48M	$220M	$229M	$229M	$238M	$92M	$96M
EBITDA Avg	$-46M	$-48M	$-220M	$-229M	$-229M	$-238M	$-92M	$-96M
Low	$-46M	$-48M	$-220M	$-229M	$-229M	$-238M	$-92M	$-96M
High	$-46M	$-48M	$-220M	$-229M	$-229M	$-238M	$-92M	$-96M
EBIT Avg	$-46M	$-48M	$-220M	$-229M	$-229M	$-238M	$-92M	$-96M
Low	$-46M	$-48M	$-220M	$-229M	$-229M	$-238M	$-92M	$-96M
High	$-46M	$-48M	$-220M	$-229M	$-229M	$-238M	$-92M	$-96M
Net Income Avg	$168,642	$170,616	$889,876	$929,000	$925,112	$949,639	$327,175	$343,207
Low	$168,642	$170,616	$889,876	$929,000	$925,112	$949,639	$327,175	$343,207
High	$168,642	$170,616	$889,876	$929,000	$925,112	$949,639	$327,175	$343,207
EPS Avg	$0.28	$0.29	$1.49	$1.55	$1.55	$1.59	$0.55	$0.57
Low	$0.28	$0.29	$1.49	$1.55	$1.55	$1.59	$0.55	$0.57
High	$0.28	$0.29	$1.49	$1.55	$1.55	$1.59	$0.55	$0.57
Analysts (Rev / EPS)	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1

Earnings Surprises

Recent Analyst Actions

Mar 11, 2025H.C. Wainwright

Checkpoint Therapeutics downgraded to Neutral from Buy at H.C. Wainwright

Target:$4.10

+2.5%from $4.00

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance